ANI Pharma (ANIP) Approves $25M Common Stock Buyback Plan

ANI Pharma (NASDAQ: ANIP) announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $25 million of shares of the Company's common stock. ANI expects to fund the stock repurchase program through cash on hand.

The authorization allows for repurchases to be conducted through open market or through privately negotiated transactions through December 31, 2016. The number of shares repurchased and the timing of repurchases will depend on a number of factors, including, but not limited to, share price, trading volume and general market conditions, along with working capital requirements, general business conditions and other factors. The stock repurchase program may be suspended, modified or discontinued at any time at ANI's discretion.

ANI had 11,489,204 shares of common stock outstanding as of September 30, 2015.

You May Also Be Interested In

• Synchrony Financial (SYF) Reports Q1, Announces $1B Share Buyback
• PPG Industries (PPG) Announces $2.5B Share Buyback
• Commerce Bancshares (CBSH) Approves Stock Repurchase Program